These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8710082)

  • 1. Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum.
    Herrero MT; Levy R; Ruberg M; Luquin MR; Villares J; Guillen J; Faucheux B; Javoy-Agid F; Guridi J; Agid Y; Obeso JA; Hirsch EC
    Neurology; 1996 Jul; 47(1):219-24. PubMed ID: 8710082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.
    Vila M; Herrero MT; Levy R; Faucheux B; Ruberg M; Guillen J; Luquin MR; Guridi J; Javoy-Agid F; Agid Y; Obeso JA; Hirsch EC
    Neurology; 1996 Mar; 46(3):802-9. PubMed ID: 8618687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons in the striatum in MPTP-treated monkeys and Parkinson's disease: an in situ hybridization study of GAD67 mRNA.
    Levy R; Herrero MT; Ruberg M; Villares J; Faucheux B; Guridi J; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA
    Eur J Neurosci; 1995 Jun; 7(6):1199-209. PubMed ID: 7582093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
    Vila M; Levy R; Herrero MT; Ruberg M; Faucheux B; Obeso JA; Agid Y; Hirsch EC
    J Neurosci; 1997 Jan; 17(2):765-73. PubMed ID: 8987798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates.
    Soghomonian JJ; Pedneault S; Audet G; Parent A
    J Neurosci; 1994 Oct; 14(10):6256-65. PubMed ID: 7931578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of A2A receptors plus l-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from l-DOPA alone in the rat globus pallidus and substantia nigra reticulata.
    Carta AR; Tabrizi MA; Baraldi PG; Pinna A; Pala P; Morelli M
    Exp Neurol; 2003 Dec; 184(2):679-87. PubMed ID: 14769359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L; Frohna PA; Joyce JN; Schneider JS
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.
    Herrero MT; Levy R; Ruberg M; Javoy-Agid F; Luquin MR; Agid Y; Hirsch EC; Obeso JA
    Adv Neurol; 1996; 69():209-16. PubMed ID: 8615130
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
    Synapse; 2006 Sep; 60(3):239-50. PubMed ID: 16739115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
    Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
    Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
    Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate decarboxylase (GAD65) mRNA levels in the striatum and pallidum of MPTP-treated monkeys.
    Pedneault S; Soghomonian JJ
    Brain Res Mol Brain Res; 1994 Sep; 25(3-4):351-4. PubMed ID: 7808234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.
    Vila M; Levy R; Herrero MT; Faucheux B; Obeso JA; Agid Y; Hirsch EC
    Neuroscience; 1996 Apr; 71(4):903-12. PubMed ID: 8684621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys.
    Herrero MT; Augood SJ; Asensi H; Hirsch EC; Agid Y; Obeso JA; Emson PC
    Brain Res Mol Brain Res; 1996 Nov; 42(1):149-55. PubMed ID: 8915594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
    Tamim MK; Samadi P; Morissette M; Grégoire L; Ouattara B; Lévesque D; Rouillard C; Di Paolo T
    Neuropharmacology; 2010 Jan; 58(1):286-96. PubMed ID: 19576910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
    Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of dizocilpine maleate (MK-801) or L-dopa reverses the increases in GAD65 and GAD67 mRNA expression in the globus pallidus in a rat hemiparkinsonian model.
    Bacci JJ; Salin P; Kerkerian-Le Goff L
    Synapse; 2002 Dec; 46(4):224-34. PubMed ID: 12373737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys.
    Soghomonian JJ; Pedneault S; Blanchet PJ; Goulet M; Di Paolo T; Bédard PJ
    Brain Res Mol Brain Res; 1996 Jul; 39(1-2):237-40. PubMed ID: 8804732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administration.
    Stephenson DT; Li Q; Simmons C; Connell MA; Meglasson MD; Merchant K; Emborg ME
    Neurobiol Dis; 2005 Nov; 20(2):347-59. PubMed ID: 15882945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.